By detecting methylation of specific bladder cancer-related methylation markers such as TERT promoter and ONECUT2 CpG sites, the method achieved a sensitivity of 94.0%, specificity of 93.1%, and an AUC of 0.961 in the validation dataset (Xu et al., 2020). This evidence concerns the gene TERT and urinary bladder carcinoma.